Tirzepatide Injection, marketed under the brand name Mounjaro, is an advanced injectable medication designed for the management of type 2 diabetes and obesity.
As a first-in-class dual agonist Tirzepatide works by targeting both GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors providing a unique and highly effective approach to controlling blood sugar levels and promoting weight loss.
This once-weekly subcutaneous injection offers a comprehensive treatment plan for individuals with type 2 diabetes by improving insulin sensitivity, reducing hepatic glucose production, and enhancing glucose-dependent insulin secretion.
Tirzepatide also helps in appetite suppression, leading to significant weight loss, making it an ideal treatment for overweight individuals with type 2 diabetes or those struggling with obesity.
Key Benefits:
- Blood Sugar Control: Improves glycemic control by regulating insulin secretion and reducing liver glucose production.
- Weight Loss: Promotes significant weight reduction, beneficial for those with both type 2 diabetes and obesity.
- Dual Action: Targets both GLP-1 and GIP receptors, offering a broader mechanism of action compared to traditional treatments.
- Convenience: A once-weekly subcutaneous injection, administered at home for patient convenience.
Usage: Tirzepatide is injected subcutaneously (under the skin) once a week. It can be administered in the abdomen, thigh, or upper arm areas. The dosage and treatment plan are tailored based on the individual’s specific medical needs, with adjustments made by the healthcare provider as necessary.
Common Side Effects:
- Nausea
- Diarrhea
- Vomiting
- Decreased appetite
- Abdominal discomfort
How it works:
- Regulates blood sugar: Tirzepatide enhances insulin secretion when blood sugar levels are high and reduces the amount of glucose released by the liver.
- Appetite control: It helps reduce appetite, leading to weight loss, which is a beneficial side effect for those with type 2 diabetes who may also be overweight.
- Improves insulin sensitivity: It may help the body use insulin more effectively, contributing to better overall blood sugar control.
Precautions:
- Not for use in individuals with type 1 diabetes or those at risk for diabetic ketoacidosis.
- Should be used with caution in individuals with a history of pancreatitis or gallbladder issues.
- Regular monitoring of blood sugar levels is recommended for optimal treatment.
Indications:
- Type 2 Diabetes Management: Helps control blood glucose levels in adults with type 2 diabetes, as part of a comprehensive lifestyle plan.
- Weight Loss: Approved for weight loss in adults with obesity or overweight who have related health conditions.
FAQ
The cost of tirzepatide injections, marketed as Mounjaro, can vary significantly depending on factors like dosage, insurance coverage, and pharmacy location. Without insurance, the price is approximately $1,135.24 for a 2 mL supply, which includes four pre-filled pens of 0.5 mL each. This breaks down to about $567.62 per pen. Dosages of 10 mg, 12.5 mg, and 15 mg per 0.5 mL share similar pricing.
Patients with insurance or those eligible for savings programs may pay significantly less. For instance, Mounjaro offers a savings card program that allows eligible patients with commercial insurance to pay as little as $25 per month, with monthly savings of up to $150.
Reviews
There are no reviews yet.